Mind Medicine (MindMed) Inc. (MNMD)

Marinus Pharmaceuticals Statistics

Total Valuation

MNMD has a market cap or net worth of $712.18 million. The enterprise value is $570.38 million.

Market Cap	712.18M
Enterprise Value	570.38M

Important Dates

The last earnings date was Thursday, July 31, 2025, after market close.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

MNMD has 76.09 million shares outstanding. The number of shares has increased by 66.46% in one year.

Current Share Class	76.09M
Shares Outstanding	76.09M
Shares Change (YoY)	+66.46%
Shares Change (QoQ)	-2.00%
Owned by Insiders (%)	1.11%
Owned by Institutions (%)	49.15%
Float	71.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.83
P/TBV Ratio	4.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.22.

Current Ratio	4.98
Quick Ratio	4.82
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-30.14

Financial Efficiency

Return on equity (ROE) is -59.11% and return on invested capital (ROIC) is -35.97%.

Return on Equity (ROE)	-59.11%
Return on Assets (ROA)	-30.55%
Return on Invested Capital (ROIC)	-35.97%
Return on Capital Employed (ROCE)	-57.37%
Revenue Per Employee	n/a
Profits Per Employee	-$1.55M
Employee Count	74
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.41% in the last 52 weeks. The beta is 2.94, so MNMD's price volatility has been higher than the market average.

Beta (5Y)	2.94
52-Week Price Change	+15.41%
50-Day Moving Average	7.87
200-Day Moving Average	7.15
Relative Strength Index (RSI)	59.28
Average Volume (20 Days)	1,287,619

Short Selling Information

The latest short interest is 11.22 million, so 14.75% of the outstanding shares have been sold short.

Short Interest	11.22M
Short Previous Month	11.17M
Short % of Shares Out	14.75%
Short % of Float	15.75%
Short Ratio (days to cover)	8.97

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-130.32M
Pretax Income	-125.32M
Net Income	-114.52M
EBITDA	-130.80M
EBIT	-130.32M
Earnings Per Share (EPS)	-$1.43

Balance Sheet

The company has $182.99 million in cash and $41.19 million in debt, giving a net cash position of $141.80 million or $1.86 per share.

Cash & Cash Equivalents	182.99M
Total Debt	41.19M
Net Cash	141.80M
Net Cash Per Share	$1.86
Equity (Book Value)	185.40M
Book Value Per Share	2.45
Working Capital	151.18M

Cash Flow

Operating Cash Flow	-101.56M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MNMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-66.46%
Shareholder Yield	-66.46%
Earnings Yield	-16.08%
FCF Yield	n/a

Analyst Forecast

The average price target for MNMD is $24.71, which is 164.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$24.71
Price Target Difference	164.00%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 29, 2022. It was a reverse split with a ratio of 1:15.

Last Split Date	Aug 29, 2022
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1